Cargando…
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
As the coronavirus disease 19 (COVID-19) global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the “off-label” repurposing of drugs such as hydroxychloroquine and lopinavir/ritonavir, which have the potential for unwanted QT-interval prolongation and a...
Autores principales: | Giudicessi, John R., Noseworthy, Peter A., Friedman, Paul A., Ackerman, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141471/ https://www.ncbi.nlm.nih.gov/pubmed/32359771 http://dx.doi.org/10.1016/j.mayocp.2020.03.024 |
Ejemplares similares
-
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic
por: Carron, Jennifer, et al.
Publicado: (2020) -
Coronavirus disease 2019 (COVID-19) and QTc prolongation
por: Changal, Khalid, et al.
Publicado: (2021) -
The Effect of COVID-19 on QTc Prolongation
por: Alsallamin, Isaac, et al.
Publicado: (2022) -
QTc interval prolongation, COVID-19 and chloroquine
por: Wiwanitkit, V.
Publicado: (2020) -
Chloroquine-induced QTc prolongation in COVID-19 patients
por: van den Broek, M. P. H., et al.
Publicado: (2020)